Cargando…
CXC Chemokine Signaling in Progression of Epithelial Ovarian Cancer: Theranostic Perspectives
Patients with epithelial ovarian cancer (EOC) are often diagnosed at an advanced stage due to nonspecific symptoms and ineffective screening approaches. Although chemotherapy has been available and widely used for the treatment of advanced EOC, the overall prognosis remains dismal. As part of the in...
Autores principales: | Huang, Xinxin, Hao, Juncheng, Tan, Yan Qin, Zhu, Tao, Pandey, Vijay, Lobie, Peter E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8910147/ https://www.ncbi.nlm.nih.gov/pubmed/35269786 http://dx.doi.org/10.3390/ijms23052642 |
Ejemplares similares
-
The Role of CXC Chemokines in Cancer Progression
por: Wu, Tiantian, et al.
Publicado: (2022) -
Catecholamines Promote Ovarian Cancer Progression through Secretion of CXC-Chemokines
por: Kim, Hyun Jung, et al.
Publicado: (2023) -
The Effect of Hypoxia on the Expression of CXC Chemokines and CXC Chemokine Receptors—A Review of Literature
por: Korbecki, Jan, et al.
Publicado: (2021) -
The Role of CXC Chemokines in Cardiovascular Diseases
por: Lu, Xiyi, et al.
Publicado: (2022) -
Screening of CXC chemokines in the microenvironment of ovarian cancer and the biological function of CXCL10
por: Li, Weiyuan, et al.
Publicado: (2021)